Tag: allergic conjunctivitis

May 15, 2017

Aldeyra Therapeutics Shares Financials for Q1 2017

Aldeyra Therapeutics released their financial results for their first quarter of 2017 and provided a corporate update.
April 18, 2017

Aldeyra Doses Last Patient in Allergic Conjunctivitis Trial

Aldeyra Therapeutics announced the last patient dosing for its Phase 2b clinical trial of ADX-102 in allergic conjunctivitis.
March 14, 2017

Tetra Bio-Pharma Enters into Binding Term Sheet for Two Products with Panag Pharma

Tetra Bio-Pharma(CSE:TBP) has entered into a binding term sheet with Panag Pharma for the development and commercialization of novel cannabinoid...
November 14, 2016

Ocular Therapeutix™ Announces Successful Topline Results from Phase 3 Clinical Trial of DEXTENZA™

Ocular Therapeutix today announced positive topline results from its phase 3 clinical trial of DEXTENZA™ (dexamethasone insert) 0.4 mg, for...
November 14, 2016

Aldeyra Therapeutics Announces Third Quarter 2016 Financial Results

Aldeyra Therapeutics, a biotechnology company focused on the development of products to treat diseases related to aldehydes, today reported third...
November 9, 2016

Ocular Therapeutix Reports Third Quarter 2016 Financial Results and Provides Corporate Update

Ocular Therapeutix, a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the...
October 11, 2016

Nicox Offers Third Quarter 2016 Business Update

Nicox, the international ophthalmic R&D company, today provided an update on its activities and cash position.